Study of Probuphine in Patients With Opioid Dependence

PHASE3TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Opioid Dependency
Interventions
DRUG

Probuphine (buprenorphine implant)

Implantable formulation of buprenorphine made of buprenorphine HCl/ethylene vinyl acetate, considered a drug. (4 implants 6-month duration)

Trial Locations (1)

33161

Scientific Clinical Research, Inc., North Miami

Sponsors
All Listed Sponsors
lead

Titan Pharmaceuticals

INDUSTRY

NCT00772785 - Study of Probuphine in Patients With Opioid Dependence | Biotech Hunter | Biotech Hunter